Significance of low level infliximab in the absence of anti-infliximab antibodies.
Ungar B, Anafy A, Yanai H, Ron Y, Yavzori M, Picard O, Fudim E, Loebstein R, Kopylov U, Chowers Y, Dotan I, Eliakim R, Ben-Horin S.
Ungar B, et al. Among authors: kopylov u.
World J Gastroenterol. 2015 Feb 14;21(6):1907-14. doi: 10.3748/wjg.v21.i6.1907.
World J Gastroenterol. 2015.
PMID: 25684959
Free PMC article.